InsidersTradesSigma
Total declarations
Company
▲ Purchases (6 ops.)
▼ Sales (0 ops.)
Browse the complete record of transactions filed by Cruz Brandon M., Directeur de la Stratégie. Director active across 1 companies, notably GoHealth, Inc.. Aggregated, 7 disclosures have been published. Total volume traded: €5m. The latest transaction was disclosed on 11 February 2022 — Retenue fiscale. Regulator: SEC (Form 4). All data is free.
Declarations7 total
€25,65015,575 shares@ €1.64690.10% mcap0.5% of flow
Class A Common Stock
SEC:0001808220-22-000007:0·
€2m530,000 shares@ €3.2456.86% mcap68.5% of flow
Class A Common Stock
SEC:0001808220-21-000070·
Ideal exit: 19 Aug 2022 (T+270)
€2m530,000 shares@ €3.2456.86% mcap34.1% of flow
Class A Common Stock
SEC:0001808220-21-000070:0·
Ideal exit: 19 Aug 2022 (T+270)
€96,87524,210 shares@ €4.00140.39% mcap3.9% of flow
Class A Common Stock
SEC:0001808220-21-000044·
Ideal exit: 15 May 2022 (T+270)
€96,87524,210 shares@ €4.00140.39% mcap1.9% of flow
Class A Common Stock
SEC:0001808220-21-000044:0·
Ideal exit: 15 May 2022 (T+270)
€695,304174,827 shares@ €3.97712.78% mcap27.7% of flow
Class A Common Stock
SEC:0001808220-21-000036·
Ideal exit: 13 May 2022 (T+270)
€695,304174,827 shares@ €3.97712.78% mcap13.8% of flow
Class A Common Stock
SEC:0001808220-21-000036:0·
Ideal exit: 13 May 2022 (T+270)
7 of 7 declarations
About Cruz Brandon M.
Brandon M. Cruz is the Chief Strategy Officer at GoHealth, Inc., a health technology company. In this role, he is responsible for defining and implementing strategies that drive growth and innovation. With a strong background in the healthcare sector, he plays a crucial role in aligning business initiatives with the company's strategic objectives.
